Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia

Summary

The purpose of this study is to find answers to the following questions: * What is the largest dose of AQ4N that can be given safely one time every three weeks for 24 weeks? * What are the side effects of AQ4N when given according to this schedule? * How much AQ4N is in the blood at certain times after administration and how does the body get rid of the drug? * Will AQ4N help treat lymphoid cancer?

Timeline

Start

2005-03

Primary completion

—

Completion

2007-03

Drugs

Indications